Miles Bridges

SF

Charlotte Hornets

Status

OUT - Hip - Soreness Expected Return: 2025-10-01

Previous game (vs. MEM 4/8)

PTS

REB

AST

BLK

STL

Latest Miles Bridges news

Bridges (hip) has been ruled out for Sunday's game against the Celtics. Bridges is dealing with left hip soreness, which will end up causing him to miss the final three games of the season. Josh Okogie and Tidjane Salaun should see a bump in minutes in Sunday's regular-season finale due to Bridges' absence. Bridges will end his sixth season in Charlotte averaging 20.3 points, 7.5 rebounds, 3.9 assists, 0.7 steals and 0.7 blocks in 31.7 minutes per game across 64 outings.

2024-25 Season Stats

PTS

REB

AST

BLK

STL

20.3

7.5

3.9

0.7

2.1

Career Averages

PTS

REB

AST

BLK

STL

15.7

6.2

2.7

0.7

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	64	64	31.7	20.3	7.5	3.9	0.7	0.7	2.1	14	1	2.2	7.0	31.3%	5.1	10.0	51.3%	7.3	17.0	43.1%	3.5	4.0	87.0%	1.1	6.4	1.5	1.8	-259	54.1%
2023-24	69	67	37.4	21.0	7.3	3.3	0.5	0.9	2.0	19	0	2.3	6.5	34.9%	5.8	11.0	52.9%	8.1	17.5	46.2%	2.5	3.1	82.5%	1.0	6.3	1.7	1.7	-633	55.6%
2021-22	80	80	35.5	20.2	7.0	3.8	0.8	0.9	1.9	15	0	1.9	5.8	33.1%	5.5	9.4	59.0%	7.5	15.2	49.1%	3.3	4.2	80.2%	1.1	5.9	2.4	2.0	+142	59.3%
2020-21	66	19	29.3	12.7	6.0	2.2	0.8	0.7	1.6	11	0	1.8	4.4	40.0%	3.0	5.0	59.3%	4.7	9.4	50.3%	1.5	1.7	86.7%	1.2	4.8	2.2	1.4	-9	62.5%
2019-20	65	64	30.7	13.0	5.6	1.8	0.7	0.6	1.5	4	0	1.5	4.6	33.0%	3.4	7.0	48.6%	4.9	11.6	42.4%	1.6	2.0	80.9%	1.4	4.2	2.0	1.2	-397	52.0%
2018-19	80	25	21.2	7.5	4.0	1.2	0.6	0.7	0.6	1	0	0.8	2.5	32.5%	2.2	3.9	55.3%	3.0	6.4	46.4%	0.7	1.0	75.3%	0.8	3.2	1.4	1.9	-127	54.8%
Career	424	319	30.8	15.7	6.2	2.7	0.7	0.8	1.6	64	1	1.7	5.1	34.0%	4.2	7.7	54.3%	5.9	12.7	46.2%	2.2	2.6	82.6%	1.1	5.1	1.9	1.7	-1283	56.4%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/15	NYK	L 111-105	15	3	3	3	1	0	0	2	1	50.0%	2	0	0.0%	4	1	25.0%	0	0	0.0%	0	3	0.0	-4	1	5	37.5%
10/10	MEM	W 119-94	18	11	2	1	0	1	4	3	1	33.3%	6	2	33.3%	9	3	33.3%	4	4	100.0%	1	1	0.3	-8	2	3	51.1%
10/8	MIA	W 111-108	20	14	9	1	0	0	2	3	0	0.0%	6	5	83.3%	9	5	55.6%	5	4	80.0%	3	6	0.5	-9	1	21	62.5%
10/6	NYK	L 111-109	21	10	6	2	0	0	1	5	2	40.0%	4	2	50.0%	9	4	44.4%	0	0	0.0%	1	5	2.0	+17	1	11	55.6%
Preseason Totals			19.0	9.5	5.0	1.8	0.3	0.3	1.8	3.3	1.0	30.8%	4.5	2.3	50.0%	7.8	3.3	41.9%	2.3	2.0	88.9%	1.3	3.8	1.0	-4	1.3	12.3	54.3%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/8	MEM	L 124-100	30	14	6	3	1	0	3	6	2	33.3%	7	2	28.6%	13	4	30.8%	4	4	100.0%	0	6	1.0	-27	2	13	47.4%
4/6	CHI	L 131-117	19	8	4	2	0	0	2	4	0	0.0%	8	3	37.5%	12	3	25.0%	4	2	50.0%	0	4	1.0	-9	1	1	29.1%
4/4	SAC	L 125-102	27	22	2	1	0	0	2	11	2	18.2%	10	5	50.0%	21	7	33.3%	6	6	100.0%	0	2	0.5	-25	2	10	46.5%
4/2	IND	L 119-105	24	18	4	5	1	0	1	3	2	66.7%	7	5	71.4%	10	7	70.0%	2	2	100.0%	1	3	5.0	+11	0	25	82.7%
3/31	UTA	W 110-106	34	26	10	8	1	1	4	6	3	50.0%	11	8	72.7%	17	11	64.7%	1	1	100.0%	3	7	2.0	+17	1	35	74.5%
3/30	NOP	L 98-94	22	20	6	2	0	1	1	6	1	16.7%	10	6	60.0%	16	7	43.8%	6	5	83.3%	1	5	2.0	+4	1	18	53.6%
3/28	TOR	L 108-97	30	11	4	6	1	1	3	9	1	11.1%	11	3	27.3%	20	4	20.0%	2	2	100.0%	0	4	2.0	-13	0	4	26.3%
3/25	ORL	L 111-104	32	11	6	4	0	0	1	8	1	12.5%	11	4	36.4%	19	5	26.3%	1	0	0.0%	2	4	4.0	+3	1	6	28.3%
3/23	MIA	L 122-105	34	17	13	4	0	0	4	7	0	0.0%	11	7	63.6%	18	7	38.9%	3	3	100.0%	6	7	1.0	-7	0	21	44.0%
3/21	OKC	L 141-106	25	20	3	4	1	1	1	10	4	40.0%	2	1	50.0%	12	5	41.7%	6	6	100.0%	0	3	4.0	-18	2	23	68.3%
3/20	NYK	W 115-98	33	15	10	4	0	0	2	5	2	40.0%	12	4	33.3%	17	6	35.3%	1	1	100.0%	0	10	2.0	+20	0	17	43.0%
3/16	LAC	L 123-88	25	7	4	3	1	0	2	7	1	14.3%	3	2	66.7%	10	3	30.0%	0	0	0.0%	0	4	1.5	-10	2	4	35.0%
3/14	SAS	W 145-134	28	21	7	8	1	0	1	7	2	28.6%	7	5	71.4%	14	7	50.0%	7	5	71.4%	1	6	8.0	+12	1	29	61.5%
3/12	ATL	L 123-110	36	31	11	5	4	2	3	8	5	62.5%	11	6	54.5%	19	11	57.9%	6	4	66.7%	0	11	1.7	-6	0	42	71.6%
3/10	MIA	W 105-102	37	35	5	5	2	0	2	11	5	45.5%	8	7	87.5%	19	12	63.2%	6	6	100.0%	0	5	2.5	+7	2	39	80.9%
3/8	BKN	W 105-102	35	26	12	5	1	1	2	6	2	33.3%	14	7	50.0%	20	9	45.0%	6	6	100.0%	3	9	2.5	+2	1	34	57.4%
3/7	CLE	L 118-117	38	46	8	2	0	2	1	10	4	40.0%	22	11	50.0%	32	15	46.9%	13	12	92.3%	1	7	2.0	+5	4	41	61.0%
3/5	MIN	L 125-110	34	23	9	5	0	0	1	8	1	12.5%	12	8	66.7%	20	9	45.0%	6	4	66.7%	1	8	5.0	+2	1	25	50.8%
3/3	GSW	L 119-101	33	35	9	3	2	0	3	9	4	44.4%	11	7	63.6%	20	11	55.0%	9	9	100.0%	1	8	1.0	-20	2	42	73.0%
3/1	WAS	L 113-100	35	18	7	7	1	0	2	6	3	50.0%	10	4	40.0%	16	7	43.8%	1	1	100.0%	4	3	3.5	-19	1	20	54.7%
2/27	DAL	L 103-96	39	20	12	6	1	0	4	8	2	25.0%	16	7	43.8%	24	9	37.5%	0	0	0.0%	0	12	1.5	-4	3	16	41.7%
2/25	GSW	L 128-92	26	9	7	2	0	0	6	5	0	0.0%	6	2	33.3%	11	2	18.2%	6	5	83.3%	1	6	0.3	-28	2	1	33.0%
2/24	SAC	L 130-88	30	23	6	1	1	0	4	8	4	50.0%	11	5	45.5%	19	9	47.4%	2	1	50.0%	2	4	0.3	-26	0	16	57.8%
2/22	POR	L 141-88	23	17	3	3	1	2	2	6	3	50.0%	8	3	37.5%	14	6	42.9%	2	2	100.0%	0	3	1.5	-28	3	14	57.1%
2/20	DEN	L 129-115	33	36	13	7	1	3	0	10	5	50.0%	13	7	53.8%	23	12	52.2%	7	7	100.0%	4	9	0.0	+1	1	51	69.0%
2/19	LAL	W 100-97	33	29	6	0	1	5	2	11	5	45.5%	11	4	36.4%	22	9	40.9%	7	6	85.7%	1	5	0.0	+4	3	24	57.8%
2/12	ORL	L 102-86	36	19	8	4	0	1	1	8	2	25.0%	15	4	26.7%	23	6	26.1%	5	5	100.0%	0	8	4.0	-18	0	13	37.7%
2/10	BKN	L 97-89	28	7	7	3	2	0	3	3	0	0.0%	8	3	37.5%	11	3	27.3%	2	1	50.0%	3	4	1.0	+2	1	6	29.5%
2/9	DET	L 112-102	36	30	9	3	0	1	4	9	5	55.6%	11	5	45.5%	20	10	50.0%	7	5	71.4%	1	8	0.8	-16	2	29	65.0%
2/7	SAS	W 117-116	34	25	7	2	1	1	0	6	3	50.0%	12	7	58.3%	18	10	55.6%	2	2	100.0%	1	6	0.0	+7	0	31	66.2%
2/5	MIL	L 112-102	26	15	6	6	0	0	1	5	1	20.0%	12	6	50.0%	17	7	41.2%	0	0	0.0%	1	5	6.0	-4	2	13	44.1%
2/3	WAS	L 124-114	36	24	10	10	0	0	2	7	2	28.6%	14	7	50.0%	21	9	42.9%	4	4	100.0%	3	7	5.0	+12	0	34	52.7%
2/1	DEN	L 107-104	33	24	12	2	1	0	1	5	1	20.0%	18	9	50.0%	23	10	43.5%	4	3	75.0%	2	10	2.0	-2	1	24	48.5%
1/31	LAC	L 112-104	37	27	9	6	0	0	3	8	1	12.5%	19	11	57.9%	27	12	44.4%	3	2	66.7%	1	8	2.0	+1	4	22	47.7%
1/29	BKN	L 104-83	31	23	13	1	2	2	2	8	1	12.5%	13	7	53.8%	21	8	38.1%	7	6	85.7%	2	11	0.5	-21	1	26	47.8%
1/27	LAL	L 112-107	36	26	8	4	1	1	2	11	2	18.2%	12	8	66.7%	23	10	43.5%	4	4	100.0%	1	7	2.0	-2	1	28	52.5%
1/25	NOP	W 123-92	28	22	6	3	1	0	2	4	2	50.0%	9	6	66.7%	13	8	61.5%	6	4	66.7%	2	4	1.5	+20	1	23	70.3%
1/22	MEM	L 132-120	34	17	5	6	0	1	4	8	2	25.0%	6	3	50.0%	14	5	35.7%	6	5	83.3%	0	5	1.5	-19	2	14	51.1%
1/20	DAL	W 110-105	32	23	5	2	1	0	3	7	4	57.1%	8	4	50.0%	15	8	53.3%	4	3	75.0%	1	4	0.7	-1	0	22	68.6%
1/17	CHI	W 125-123	31	21	4	3	0	1	3	6	3	50.0%	9	5	55.6%	15	8	53.3%	2	2	100.0%	1	3	1.0	+15	2	18	66.1%
1/15	UTA	W 117-112	38	25	10	4	1	1	1	7	3	42.9%	9	6	66.7%	16	9	56.3%	4	4	100.0%	2	8	4.0	+25	3	31	70.4%
1/12	PHX	L 120-113	32	21	5	5	0	0	2	5	3	60.0%	10	5	50.0%	15	8	53.3%	2	2	100.0%	0	5	2.5	+8	3	20	66.1%
1/7	PHX	W 115-104	36	21	7	3	0	2	1	5	2	40.0%	12	6	50.0%	17	8	47.1%	3	3	100.0%	1	6	3.0	+5	4	19	57.3%
1/5	CLE	L 115-105	26	11	8	3	0	1	1	6	1	16.7%	8	4	50.0%	14	5	35.7%	0	0	0.0%	1	7	3.0	-14	3	10	39.3%
1/3	DET	L 98-94	39	20	9	5	1	2	6	7	3	42.9%	9	2	22.2%	16	5	31.3%	9	7	77.8%	0	9	0.8	-3	2	17	50.1%
12/30	CHI	L 115-108	36	31	12	8	0	0	3	13	2	15.4%	19	11	57.9%	32	13	40.6%	3	3	100.0%	1	11	2.7	+2	2	28	46.5%
12/28	OKC	L 106-94	38	19	10	6	2	1	3	8	1	12.5%	8	4	50.0%	16	5	31.3%	8	8	100.0%	1	9	2.0	-3	1	27	48.7%
12/26	WAS	L 113-110	33	22	14	6	2	1	2	9	4	44.4%	8	4	50.0%	17	8	47.1%	2	2	100.0%	1	13	3.0	+1	0	33	61.5%
12/23	HOU	L 114-101	29	24	8	3	0	1	2	6	2	33.3%	11	7	63.6%	17	9	52.9%	4	4	100.0%	0	8	1.5	-7	0	28	64.0%
12/20	PHI	L 108-98	28	15	7	1	2	1	5	7	1	14.3%	6	3	50.0%	13	4	30.8%	6	6	100.0%	1	6	0.2	-19	2	12	48.0%
12/19	WAS	L 123-114	31	16	8	3	0	0	2	4	0	0.0%	12	7	58.3%	16	7	43.8%	3	2	66.7%	1	7	1.5	-7	2	13	46.2%
12/16	PHI	L 121-108	28	24	6	4	0	0	3	8	2	25.0%	11	8	72.7%	19	10	52.6%	3	2	66.7%	1	5	1.3	+2	1	23	59.1%
12/13	CHI	L 109-95	24	14	9	4	1	0	0	6	0	0.0%	10	5	50.0%	16	5	31.3%	4	4	100.0%	3	6	0.0	-1	2	16	39.4%
11/19	BKN	L 116-115	33	21	3	2	0	0	1	9	5	55.6%	5	3	60.0%	14	8	57.1%	0	0	0.0%	0	3	2.0	-15	1	16	75.0%
11/17	CLE	L 128-114	26	19	8	8	1	2	0	8	4	50.0%	7	3	42.9%	15	7	46.7%	1	1	100.0%	1	7	0.0	-15	2	28	61.5%
11/16	MIL	W 115-114	26	19	7	3	0	1	1	7	3	42.9%	8	4	50.0%	15	7	46.7%	2	2	100.0%	2	5	3.0	+4	0	22	59.8%
11/6	DET	W 108-107	35	27	7	2	0	0	0	3	2	66.7%	11	6	54.5%	14	8	57.1%	9	9	100.0%	1	6	0.0	+6	3	33	75.2%
11/4	MIN	L 114-93	25	10	6	4	0	0	1	6	1	16.7%	7	3	42.9%	13	4	30.8%	2	1	50.0%	1	5	4.0	-10	1	8	36.0%
11/2	BOS	L 113-103	31	6	8	5	0	2	3	2	1	50.0%	4	1	25.0%	6	2	33.3%	2	1	50.0%	0	8	1.7	-4	1	13	43.6%
11/1	BOS	L 124-109	31	14	7	3	0	1	1	10	2	20.0%	6	3	50.0%	16	5	31.3%	3	2	66.7%	0	7	3.0	-12	1	13	40.4%
10/30	TOR	W 138-133	23	7	3	2	1	0	2	7	1	14.3%	4	1	25.0%	11	2	18.2%	2	2	100.0%	0	3	1.0	-12	0	2	29.5%
10/26	MIA	L 114-106	34	16	9	2	1	0	2	6	2	33.3%	8	4	50.0%	14	6	42.9%	4	2	50.0%	2	7	1.0	+0	2	15	50.8%
10/25	ATL	L 125-120	30	27	5	0	1	0	0	8	3	37.5%	9	5	55.6%	17	8	47.1%	8	8	100.0%	1	4	0.0	-16	3	26	65.8%
10/23	HOU	W 110-105	32	10	9	2	1	1	4	3	0	0.0%	8	5	62.5%	11	5	45.5%	0	0	0.0%	0	9	0.5	+4	1	11	45.5%
Regular Season Totals			31.7	20.3	7.5	3.9	0.7	0.7	2.1	7.0	2.2	31.3%	10.0	5.1	51.3%	17.0	7.3	43.1%	4.0	3.5	87.0%	1.1	6.4	1.8	-259	1.5	23.6	54.1%

Miles Bridges

SF

Status

Previous game (vs. MEM 4/8)

Latest Miles Bridges news

Not playing Sunday

2024-25 Season Stats

Miles Bridges Career Stats

Career Averages

Miles Bridges Season Stats

2024-25

2023-24

2021-22

2020-21

2019-20

2018-19

Previous Game (vs. MEM 4/8)

2024-25 Stats

2024-25 Rebounding

2024-25 Defensive

2024-25 Shooting

2024-25 Advanced

Miles Bridges Game Log

2024-25

2023-24

2021-22

2020-21

2019-20

2018-19

Miles Bridges Player Profile

Career History

Miles Bridges Latest News

Not playing Sunday

Won't play against Boston

Sitting out Wednesday

Paces Charlotte in lackluster night

Good to go Tuesday

Questionable for Tuesday

Struggles with shot Friday

Puts up 18 points Wednesday

Available vs. Indiana

Miles Bridges

SF

Unlock the latest Charlotte Hornets news — direct to your inbox.

Status

Previous game (vs. MEM 4/8)

Latest Miles Bridges news Subscribe

2024-25 Season Stats

Latest Miles Bridges news